Regulatory B cells: role in type 1 diabetes

Boldison, Joanne and Wong, F. Susan ORCID: https://orcid.org/0000-0002-2812-8845 2021. Regulatory B cells: role in type 1 diabetes. Frontiers in Immunology 12 , 746187. 10.3389/fimmu.2021.746187

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (476kB) | Preview

Abstract

Regulatory B cells (Bregs) have an anti-inflammatory role and can suppress autoimmunity, by employing both cytokine secretion and cell-contact mediated mechanisms. Numerous Breg subsets have been described and have overlapping phenotypes in terms of their immune expression markers or cytokine production. A hallmark feature of Bregs is the secretion of IL-10, although IL-35 and TGFβ−producing B cells have also been identified. To date, few reports have identified an impaired frequency or function of Bregs in individuals with type 1 diabetes; thus our understanding of the role played by these Breg subsets in the pathogenesis of this condition is limited. In this review we will focus on how regulatory B cells are altered in the development of type 1 diabetes, highlighting both frequency and function and discuss both human and animal studies.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Additional Information:	This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
Publisher:	Frontiers Media
ISSN:	1664-3224
Date of First Compliant Deposit:	18 November 2021
Date of Acceptance:	2 September 2021
Last Modified:	09 May 2023 18:20
URI:	https://orca.cardiff.ac.uk/id/eprint/145598

Citation Data

Cited 3 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item